openPR Logo
Press release

PROTAC Market Set Transforming Therapeutics for Explosive Growth in Targeted Drug Development | Bristol Myers Squibb (BMS) and Pfizer

10-22-2024 11:46 AM CET | Health & Medicine

Press release from: CoherentMI

PROTAC Market

PROTAC Market

A new report published by CoherentMI, titled "PROTAC Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the PROTAC market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The Global PROTAC Market is estimated to be valued at USD 0.40 billion in 2024 and is expected to reach USD 2.59 billion by 2031, growing at a compound annual growth rate (CAGR) of 25.1% from 2024 to 2031.

This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The PROTAC market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the PROTAC market, including market size, trends, drivers and constraints, competitive aspects, and prospects for future growth.

Request a Sample Copy with More Details: - https://www.coherentmi.com/industry-reports/protac-market/request-sample

Scope of the PROTAC Market:

The PROTAC market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Major Players Operating in the PROTAC Market:

• Arvinas
• Celgene
• Nurix Therapeutics
• Hinova Pharmaceuticals
• Dialectic Therapeutics
• Accutar Biotech
• Kymera
• Sanofi
• Bristol Myers Squibb (BMS) and Pfizer

PROTAC Market Segments:

❖ By Type
• Heterobifunctional PROTAC
• Molecular Glues
• Others

❖ By Application
• Drug Discovery and Development
• Cancer Research
• Neurodegenerative Diseases
• Infectious Diseases
• Others

❖ By Therapeutic Area
• Oncology
• Neurology
• Infectious Diseases
• Cardinology
• Endocrinology

❖ By End-user
• Pharmaceutical
• Academic and Research Institutes
• Contract Research Organizations

Geographical Landscape:

The PROTAC Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.

➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

This report offers actionable growth insights and an extensive study comprising secondary research, primary interviews with industry stakeholders, and competitors, validation, and triangulation with the CoherentMI regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.

Trends and Opportunities:

The PROTAC market has seen several trends in recent years, and understanding these trends is crucial to stay ahead of the competition. The increasing demand for PROTAC in various industries presents several growth opportunities for players in the market.

Would you like to have an opportunity to explore more explore more details, If yes, access our full report @ https://www.coherentmi.com/industry-reports/protac-market

Key Benefits for Stakeholders:

⏩ The study includes a comprehensive analysis of current PROTAC Market trends, estimations, and market size dynamics from 2024 to 2031 in order to identify the most potential prospects.

⏩ The five forces study by Porter underlines the role of buyers and suppliers in aiding stakeholders in making profitable business decisions and expanding their supplier-buyer network.

⏩ In-depth research, as well as market size and segmentation, can assist you in identifying current PROTAC Market opportunities.

⏩ The largest countries in each area are mapped based on their market revenue contribution.

⏩ The PROTAC Market research report provides an in-depth analysis of the top competitors in the market.

Global PROTAC Market 2024 Key Insights:

▶ Research and analyze the PROTAC Market standing and future forecast associated with production, Market price structure, consumption, and historical knowledge.

▶ The report understands the structure of PROTAC Market trade by distinctive its varied segments and sub-segments.

▶ Market report split the breakdown knowledge by company, products, end-user, and prime countries, with market history knowledge from 2017 to 2024 and forecast to 2031.

▶ Analysis of PROTAC Market regarding individual growth trends, future prospects, and their contribution to the overall market.

▶ Global PROTAC Market 2024 report analyzes competitive expansions like agreements, new product launches, and acquisitions.

▶ This research report targets the global key players to characterize sales volume, market revenue, growth potential, drivers, SWOT analysis, and development plans in coming years.

Get access to the latest Edition of this Market Study (comprising 150 + pages ) @ https://www.coherentmi.com/industry-reports/protac-market/buynow

Reasons to buy:

👉 Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

👉 Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

👉 Classify potential new clients or partners in the target demographic.

👉 Develop tactical initiatives by understanding the focus areas of leading companies.

👉 Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.

👉 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

👉 Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Author Bio:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

More Trending Reports by CoherentMI Market:

Gestational Diabetes Market https://www.coherentmi.com/industry-reports/gestational-diabetes-market

Giant Papillary Conjunctivitis Market https://www.coherentmi.com/industry-reports/giant-papillary-conjunctivitis-market

Heart Pump Device Market https://www.coherentmi.com/industry-reports/heart-pump-device-market

Hand Foot Syndrome Market https://www.coherentmi.com/industry-reports/hand-foot-syndrome-market

☎ Contact Us:

Mr. Shah
CoherentMI,
U.S.: +1-650-918-5898
U.K: +44-020-8133-4027
Australia: +61-2-4786-0457
INDIA: +91-848-285-0837
Email: sales@coherentmi.com
Website: https://www.coherentmi.com

About CoherentMI:

At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PROTAC Market Set Transforming Therapeutics for Explosive Growth in Targeted Drug Development | Bristol Myers Squibb (BMS) and Pfizer here

News-ID: 3704084 • Views:

More Releases from CoherentMI

How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 - Growth, Segments, and Revenue Trends| Otsuka Pharmaceutical, Reata Pharmaceuticals
How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 …
The latest report on the "Autosomal Dominant Polycystic Kidney Disease Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts, and Emerging Frontiers |Nicox, Qlaris Bio, TheratOcular Biotek Co.Ltd.
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts …
The latest report on the "Ocular Hypertension Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors such
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportunities, and Key Trends |Epizyme, Eli Lilly and Company, Pfizer, Merck Sharp & Dohme
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportun …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Epithelioid Sarcoma Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and Growth Through 2032 |Genentech, GlaxoSmithKline, Clovis Oncology, AstraZeneca
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and …
The latest report on the "Clear Cell Ovarian Cancer Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical

All 5 Releases


More Releases for PROTAC

Proteolysis Targeting Chimera Protac Market Gains Traction Amid Technological Ad …
New Jersey, US State: "The global Proteolysis Targeting Chimera Protac market in the Healthcare and Pharmaceuticals category is projected to reach USD 5.3 billion by 2031, growing at a CAGR of 23.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 1.2 billion in 2024, highlighting strong growth potential throughout the forecast period." Proteolysis Targeting Chimera (PROTAC)
PROTAC Market to See Booming Growth 2025-2032 | Arvinas, Celgene, Nurix Therapeu …
The Global PROTAC Market is estimated to be valued at USD 0.50 billion in 2025 and is expected to reach USD 2.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 25.3% from 2025 to 2032. According to the latest research from CoherentMI, the PROTAC Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough research,
The PROTAC market is anticipated to experience robust expansion over the forecas …
(Albany, USA) DelveInsight's PROTAC Market Insights report offers an in-depth analysis of existing treatment approaches, upcoming PROTAC therapies, the market share of each therapy, and projected as well as current market size for PROTACs from 2020 to 2034. The data is segmented across the 7 major markets (7MM), including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The PROTAC market is anticipated to expand considerably
PROTAC Market Industry Trends, Growth Projections, and Market Share Report 2024 …
A new Report by CoherentMI Market Reports, titled "PROTAC Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the PROTAC market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The Global PROTAC Market is estimated to be valued at USD 0.40 billion in 2024 and is expected to reach USD 2.59 billion
PROTAC Cancer Therapy PROTAC Drugs Clinical Trials Insight
Global Proteolysis Targeting Chimeras PROTAC Therapy Clinical Trials Insight & Market Opportunity Report Highlights: • First PROTAC Drug Approval Expected By 2027 • Insight On More Than 50 PROTAC Drugs In Clinical Trials • Global PROTAC Drugs Clinical Trials Insight By Company, Country, Indication & Phase • Orphan & Fast Track Designation Insight • PROTAC Drugs Clinical Application & Development Outlook By Indication • Current & Future Market Overview • Global PROTAC Drug Market Dynamics Download Report: https://www.kuickresearch.com/ccformF.php?t=1728551968 PROTACs, or proteolysis-targeting chimeras, have emerged as a
Protac Drug Market Growth Forecast and Industry Challenges 2024-2032 -Bicycle Th …
The global Protac Drug market size was valued at USD 86.86 USD Billion in 2032 and is poised to grow at a significant CAGR of 40.97% during the forecast period of 2024-2032. It also includes market size and projection estimations for each of the five major regions from 2024 to 2032. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes